FDA approves generic Imitrex, Eloxatin from Sun

08/12/2009 | Reuters

Sun Pharmaceutical Industries obtained FDA clearance for its generic copies of GlaxoSmithKline's migraine drug Imitrex and Sanofi-Aventis' cancer drug Eloxatin. The Indian company said it will share a 180-day market protection for generic Eloxatin with three other drug firms.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations